Author

Vincent R. Mirabella

Rutgers, The State University of New Jersey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:electronic health records· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

ChangHui PakiD· 2 shared Thomas Christian SüdhofiD· 2 shared Zhiping P. PangiD· 2 shared Alexander Eckehart UrbaniD· 1 shared Alexis MitelpunktiD· 1 shared Azadeh Jadali· 1 shared Bradley J. Swanson· 1 shared Bruce J. AronowiD· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

ChangHui PakORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeuroscienceMolecular PsychiatryPeer-reviewedOct 24, 2022

Analyses of the Autism-associated Neuroligin-3 R451C Mutation in Human Neurons Reveals a Gain-of-Function Synaptic Mechanism

Le Wang, Vincent R. Mirabella, Rujia Dai…·Zhiping P. Pang

The paper investigates the impact of the NLGN3 R451C mutation on human neurons, finding it reduces protein levels but enhances excitatory synapses, potentially contributing to ASD pathogenesis.

53 citationstop 3%

humanscRNA-seq

𝕏 PostBluesky

NeuroscienceProceedings of the National Academy of SciencesPeer-reviewedMay 25, 2021

Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived NRXN1-Mutant Neurons

ChangHui Pak, Tamás Dankó, Vincent R. Mirabella…·Thomas Christian Südhof

This study validates that heterozygous NRXN1 deletions impair neurotransmitter release in human neurons across multiple labs, suggesting a human-specific synaptic dysfunction relevant for schizophrenia drug discovery.

81 citationstop 1%

humanmouse

𝕏 PostBluesky